- Title
- TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab
- Creators
- Stefan GLÜCK - Division of Hematology/Oncology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Leonard M. Miller School of Medicine, 1475 NW 12th Ave., Suite 3510, Miami, FL 33136, United StatesJeffrey S ROSS - Albany Medical Center, 43 New Scotland Avenue, Albany, NY 12208, United StatesMelanie ROYCE - University of New Mexico Cancer Research and Treatment Center, 7801 Academy, Albuquerque, NM 87109, United StatesEdward F MCKENNA - Roche Inc., 340 Kingsland Street, Nutley, NJ 07110, United StatesCharles M PEROU - Lineberger Comprehensive Cancer Center and University of North Carolina at Chapel Hill, CB 7295, Chapel Hill, NC 27599, United StatesEli AVISAR - Division of Hematology/Oncology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Leonard M. Miller School of Medicine, 1475 NW 12th Ave., Suite 3510, Miami, FL 33136, United StatesLIN LIN WU - Roche Molecular Diagnostics, 4300 Hacienda Drive, Pleasanton, CA 94588, United States
- Publication Details
- Breast cancer research and treatment, Vol.132(3), pp.781-791
- Publisher
- Springer; Dordrecht
- Academic Unit
- Miller School of Medicine; UMMG Department of Surgery; UMMG Dept of Surgery - Div of Surgical Oncology
- Language
- English
- Resource Type
- Journal article
- PMID
- 21373875
- Record Identifier
- 991031575926102976
Journal article
TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab
Breast cancer research and treatment, Vol.132(3), pp.781-791
2012
PMID: 21373875
Metrics
7 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Industry collaboration
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.119 Breast Cancer Scanning
- 1.119.259 HER2
- Web Of Science research areas
- Oncology
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites